COPD: Providing the right treatment for the right patient at the right time

Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with significant morbidity and mortality that is both preventable and treatable.
However, a major challenge in recognizing, preventing, and treating COPD is understanding its complexity. While COPD has historically been characterized as a disease defined by airflow limitation, we now understand it as a multi-component disease with many clinical phenotypes, systemic manifestations, and associated co-morbidities.
Puedes leer el artículo completo en el siguiente enlace: https://www.resmedjournal.com/article/S0954-6111(22)00306-7/fulltext#secsectitle0010
Autores:
Alvar Agusti, Nicolino Ambrosino, Felicity Blackstock, Jean Bourbeau, Richard Casaburi, Bartolome Celli, Rebecca Crouch,Roberto Dal Negro,, Michael Dreher, Christine Garvey, Daniel Gerardi, Roger Goldstein, Nicola Hanania, Anne E. Holland, Antarpreet Kaur, Suzanne Lareau, Peter K., Lindenauer, David Mannino, Barry Make, François Maltais, Jeffrey D. Marciniuk, Paula Meek, Mike Morgan, Jean-Louis, Pepin, Jane Z. Reardon, Carolyn, Rochester, Sally Singh, Martijn, A. Spruit, Michael C. Steiner, Thierry Troosters, Michele, Vitacca, Enico Clini, Jose Jardim, Linda Nici, Jonathan Raskin, Richard ZuWallack.
Noticias relacionadas

Vídeo de la Presentación de las Novedades GOLD 2024
Vídeo de la Presentación de las Novedades Gold 2024 del 21 de Noviembre de 2023, de 17 a 19h.

Reunión «Chiesi PatienTalks» con la participación de Alvar Agustí como moderador
Alvar Agustí participará como coordinador científico de la Reunión “CHIESI PatienTalks” que con el patrocinio de Chiesi, se llevará a cabo el miércoles 29 de noviembre de 2023 en la Real Academia de Medicina de Barcelona.
Más artículos
EPOC
- 769092·Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
- 769273· Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- 769280·Alvar Agusti, M.D., Ph.D. – Biologics for COPD — Finally Here
- 769393·D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti. When GETomics meets aging and exercise in COPD
- 769699·Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
COPD
- 769092·Leonardo M Fabbri et al. COPD and multimorbidity: recognising and addressing a syndemic occurrence
- 769273· Singh D, Criner GJ, Agustí A et al. Benralizumab Prevents Recurrent Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis
- 769280·Alvar Agusti, M.D., Ph.D. – Biologics for COPD — Finally Here
- 769393·D. Pellegrino, S. Casas-Recasens, R. Faner, P. Palange, A. Agusti. When GETomics meets aging and exercise in COPD
- 769699·Alvar Agustí et al.- GOLD 2023: What’s New, Doc?
Recuerda que puedes acceder a varios enlaces a artículos en el Listado de Artículos de la Cátedra de Salud Respiratoria.
Imágenes obtenidas el 19/01/2023 en Canva Pro.